ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2026
CDK4/6 inhibitors for premenopausal women with hormone receptor-positive/HER2-negative breast cancer; insight from Young-PEARL.
Eriko TokunagaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.